Maxillary osteonecrosis related to post-COVID-19: A report of case series and 6-month follow-up
Authors:
Open Access
- 18 June 2024
- journal article
- research article
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (1) , 180-187
Abstract
No abstract availableKeywords
Funding Information
- Oregon Health and Science University
This publication has 28 references indexed in Scilit:
- Use of steroids in COVID-19 patients: A meta-analysisEuropean Journal of Pharmacology, 2021
- Biology of COVID-19 and related viruses: Epidemiology, signs, symptoms, diagnosis, and treatmentBest Practice & Research Clinical Anaesthesiology, 2021
- Impact of COVID-19 disease and its treatment on the development of maxillofacial complicationsAdvances in Oral and Maxillofacial Surgery, 2021
- Aspects of maxillar osteomyelitis in patients who had COVID-19 in UzbekistanAdvances in Oral and Maxillofacial Surgery, 2021
- Complications of COVID-19 in the maxillo-facial region: Clinical case and review of the literatureAdvances in Oral and Maxillofacial Surgery, 2021
- The PROCESS 2020 Guideline: Updating Consensus Preferred Reporting Of CasE Series in Surgery (PROCESS) GuidelinesInternational Journal of Surgery, 2020
- Differences between osteoradionecrosis and medication-related osteonecrosis of the jawOral and Maxillofacial Surgery, 2017
- The role of vasculature in bone development, regeneration and proper systemic functioningAngiogenesis, 2017
- Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015Osteoporosis International, 2015
- Posterior and anterior components of force during bite loadingJournal of Biomechanics, 2007